Q4 2017 Holdings
Filed 2018-02-13 | 13 holdings | $28.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $21.2M | 529,343 | 74.9% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $6.2M | 251,936 | 22.0% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $760.0K | 150,592 | 2.7% |
| Insmed Incorporated(INSM) | COM | 457669307 | $27.4K | 879,910 | 0.1% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $20.7K | 2,254,502 | 0.1% |
| Immunomedics, Inc.(IMMU) | COM | 452907108 | $17.3K | 1,073,272 | 0.1% |
| Myokardia, Inc. | COM | 62857M105 | $13.0K | 309,357 | 0.0% |
| uniQure N.V.(QURE) | SHS | N90064101 | $12.4K | 635,234 | 0.0% |
| OptiNose, Inc. | COM | 68404V100 | $8.5K | 450,000 | 0.0% |
| Biohaven Pharmaceutical Holding Company Ltd.(BHVN) | COM | G11196105 | $5.8K | 213,435 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $5.1K | 175,000 | 0.0% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $2.7K | 232,909 | 0.0% |
| Denali Therapeutics Inc.(DNLI) | COM | 24823R105 | $1.5K | 94,666 | 0.0% |